En vivo
CellCellular architecture and neighborhood-informed virtual spatial tumor profiling from histopathologyCellA CRISPR knockout mouse library for functional genomics in influenza researchEndpoints NewsMigraine biotech Vedana Therapeutics makes its debut with $46M Series ABioPharma DiveA new Westlake-backed biotech takes aim at migraineseLifeCorrection: The myeloid cell-driven transdifferentiation of endothelial cells into pericytes promotes the restoration of BBB function and brain self-repair after stroke10x Genomics NewsTXG (Nasdaq) RSU vesting entries listed on Form 144 with JP Morgan intermediary - Stock TitanClinical OMICsCancer Diagnostics: Droplet Digital PCR Testing for HPV+ Cancer in the ClinicEndpoints NewsHealth groups say HHS is trying to 'rush reinstatement' of ACIPEndpoints NewsB cell therapy maker Be Bio stops hemophilia trialClinical OMICsFibroblast Signaling Pathways Linked to Angiogenesis Differences in NSCLCEndpoints NewsFDA raises no major red flags with Moderna's flu shotFierceBiotechEli Lilly’s M&A spree continues with acquisition of non-opioid pain drugmaker 4E

Archivo

Reciente Más antiguo Borrar
@MACHEREY-NAGEL GmbH & Co. KG
Total 26
Fuente MACHEREY-NAGEL GmbH & Co. KG
Búsqueda --